logo
Select company
Select metric
-41.22%Free Cash Flow Yield
VS
Market
12
Sector
31
Industry
42
History
19
$ 14.01Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - Free Cash Flow Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - FCF Yield Historical data
DateFree Cash FlowFree Cash Flow YieldMarket Capitalization
6/30/2025$ -274.85M-41.22%$ 666.87M
3/31/2025$ -282.79M-120.56%$ 234.58M
12/31/2024$ -266.9M-64.96%$ 410.86M
9/30/2024$ -247.72M-19.58%$ 1.26B
6/30/2024$ -216.95M-30.98%$ 700.23M
3/31/2024$ -168.39M-28.51%$ 590.62M
12/31/2023$ -139.21M-26.19%$ 531.56M
9/30/2023$ -136.05M-30.23%$ 450M
6/30/2023$ -138.35M-15.52%$ 891.53M
3/31/2023$ -142.28M-26.25%$ 542.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) FCF Yield stands at -5.48%.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average FCF Yield has been -33.05%.
  • The median FCF Yield for PHATHOM PHARMACEUTICALS INC during this period was -27.38%
  • PHATHOM PHARMACEUTICALS INC reached its highest FCF Yield over the past 5 years at -5.48%.
  • The lowest FCF Yield recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe -120.56%

PHATHOM PHARMACEUTICALS INC's FCF Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Yield Benchmarks
CompanyFCF Yield
GYRE : GYRE THERAPEUTICS INC 0.01%ANAB : ANAPTYSBIO INC -20.3%NAGE : NIAGEN BIOSCIENCE INC 2.8%CRMD : CORMEDIX INC 3.77%TBPH : THERAVANCE BIOPHARMA INC 39.13%ZYME : ZYMEWORKS INC -4.43%URGN : UROGEN PHARMA LTD -14.36%ZVRA : ZEVRA THERAPEUTICS INC -7.05%XNCR : XENCOR INC -25.33%KURA : KURA ONCOLOGY INC 23.75%

Definition of Free Cash Flow Yield

[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
FCF / Market Cap
(=) FCF Yield
FCF Yield for PHATHOM PHARMACEUTICALS INC is calculated as follows: FCF [ $ -65.89M ] / Market Cap [ $ 1.2B ]
(=) FCF Yield [ -5.48% ]

PHAT - Free Cash Flow Yield, Last 5 years

-120.56%

Minimum

Mar 31, 2025

-5.48%

Maximum

Sep 30, 2020

-33.05%

Average

-27.38%

Median

FCF Yield Benchmark Analysis

The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.58% with a standard deviation of 11.38%.
The following table provides additional summary stats:
FCF Yield in the Market:
filtered constituents3.58K
min-33.87%
max37.55%
average1.58%
median3.22%
std11.38%